Search Results - "Maynard, N. D."

Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinoma by MacGregor, T. P., Carter, R., Gillies, R. S., Findlay, J. M., Kartsonaki, C., Castro-Giner, F., Sahgal, N., Wang, L. M., Chetty, R., Maynard, N. D., Cazier, J. B., Buffa, F., McHugh, P. J., Tomlinson, I., Middleton, M. R., Sharma, R. A.

“…Oxaliplatin-based chemotherapy is used to treat patients with esophageal adenocarcinoma (EAC), but no biomarkers are currently available for patient selection…”
Get full text

Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma by Gillies, R. S., Middleton, M. R., Han, C., Marshall, R. E. K., Maynard, N. D., Bradley, K. M., Gleeson, F. V.

“…Background: Positron emission tomography combined with computed tomography (PET–CT) is increasingly being used in the staging of oesophageal cancer. Some…”
Get full text

Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro‐oesophageal cancer by Boer, R. B., Jones, K. I., Ash, S., Boxel, G. I., Gillies, R. S., O'Donnell, T., Ruurda, J. P., Sgromo, B., Silva, M. A., Maynard, N. D.

“…Background Risk assessment is relevant to predict postoperative outcomes in patients with gastro‐oesophageal cancer. This cohort study aimed to assess body…”
Get full text

A comparison of the left thoracoabdominal and Ivor–Lewis esophagectomy by Davies, A R, Zylstra, J, Baker, C R, Gossage, J A, Dellaportas, D, Lagergren, J, Findlay, J M, Puccetti, F, El Lakis, M, Drummond, R J, Dutta, S, Mera, A, Van Hemelrijck, M, Forshaw, M J, Maynard, N D, Allum, W H, Low, D, Mason, R C

“…SUMMARY The purpose of this study was to assess the oncological outcomes of a large multicenter series of left thoracoabdominal esophagectomies, and compare…”
Get full text

Pragmatic staging of oesophageal cancer using decision theory involving selective endoscopic ultrasonography, PET and laparoscopy by Findlay, J. M., Bradley, K. M., Maile, E. J., Braden, B., Maw, J., Phillips-Hughes, J., Gillies, R. S., Maynard, N. D., Middleton, M. R.

“…Background Following CT, guidelines for staging oesophageal and gastro‐oesophageal junction (GOJ) cancer recommend endoscopic ultrasonography (EUS), PET–CT and…”
Get full text

Brachytherapy in the Palliation of Oesophageal Cancer: Effective but Impractical? by Sinha, S., Varagunam, M., Park, M.H., Maynard, N.D., Trudgill, N., Crosby, T., Cromwell, D.A.

“…Dysphagia in people with advanced oesophageal cancer can be treated by oesophageal stents, external beam radiotherapy (EBRT) and intraluminal brachytherapy…”
Get full text

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer by Findlay, J. M., Bradley, K. M., Wang, L. M., Franklin, J. M., Teoh, E. J., Gleeson, F. V., Maynard, N. D., Gillies, R. S., Middleton, M. R.

“…Background The ability to predict recurrence and survival after neoadjuvant chemotherapy (NAC) and surgery for oesophageal cancer remains elusive. This study…”
Get full text

The effect of formalizing enhanced recovery after esophagectomy with a protocol by Findlay, J. M., Tustian, E., Millo, J., Klucniks, A., Sgromo, B., Marshall, R. E. K., Gillies, R. S., Middleton, M. R., Maynard, N. D.

“…Summary Enhanced recovery after surgery (ERAS) pathways aim to accelerate functional return and discharge from hospital. They have proven effective in many…”
Get full text

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer by Findlay, J. M., Bradley, K. M., Wang, L. M., Franklin, J. M., Teoh, E. J., Gleeson, F. V., Maynard, N. D., Gillies, R. S., Middleton, M. R.

Get full text

Attempted validation of the NUn score and inflammatory markers as predictors of esophageal anastomotic leak and major complications by Findlay, J. M., Tilson, R. C., Harikrishnan, A., Sgromo, B., Marshall, R. E. K., Maynard, N. D., Gillies, R. S., Middleton, M. R.

“…Summary The ability to predict complications following esophagectomy/extended total gastrectomy would be of great clinical value. A recent study demonstrated…”
Get full text

Metabolic response at repeat PET/CT predicts pathological response to neoadjuvant chemotherapy in oesophageal cancer by Gillies, R. S., Middleton, M. R., Blesing, C., Patel, K., Warner, N., Marshall, R. E. K., Maynard, N. D., Bradley, K. M., Gleeson, F. V.

“…Objectives Reports have suggested that a reduction in tumour 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) examination during or…”
Get full text

Granular cell tumour of the oesophagus mimicking a gastrointestinal stromal tumour on frozen section by Prematilleke, I V, Sujendran, V, Warren, B F, Maynard, N D, Piris, J

Get full text

Flowering, sex expression, and fruiting of pumpkin (Cucurbita sp.) cultivars under various temperatures in greenhouse and distant field trials by Wien, H.C, Stapleton, S.C, Maynard, D.N, McClurg, C, Riggs, D

“…Field production of decorative pumpkins (Cucurbita pepo L.) in New York occasionally results in markedly delayed fruit production in spite of normal vine…”
Get full text

Gastrointestinal stromal tumour (GIST) masquerading as linitis plastica by Wheeler, J M D, Warren, B F, Sica, G, Maynard, N D

Get full text

Liver function and splanchnic ischemia in critically ill patients by Maynard, N D, Bihari, D J, Dalton, R N, Beale, R, Smithies, M N, Mason, R C

“…To investigate the concept that splanchnic ischemia leads to hepatic dysfunction in the critically ill. Prospective study and analysis of patient data. A…”
Get more information

Left thoracoabdominal esophagectomy: results from a single specialist center by Gillies, R. S., Simpkin, A., Sgromo, B., Marshall, R. E. K., Maynard, N. D.

“…SUMMARY The left thoracoabdominal approach to esophagectomy is not widely performed, despite offering excellent exposure to tumors of the esophagogastric…”
Get full text

Additional benefit of 18F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer by Gillies, R. S., Middleton, M. R., Maynard, N. D., Bradley, K. M., Gleeson, F. V.

“…Objective 18 F-fluorodeoxyglucose positron emission tomography (FDG PET) has been shown to improve the accuracy of staging in oesophageal cancer. We assessed…”
Get full text

Postoperative feeding by Maynard, N D, Bihari, D J

Get full text

Oxford experience with neoadjuvant chemotherapy and surgical resection for esophageal adenocarcinomas and squamous cell tumors by Safranek, P. M., Sujendran, V., Baron, R., Warner, N., Blesing, C., Maynard, N. D.

“…The Medical Research Council trial for oesophageal cancer (OEO2) trial demonstrated a clear survival benefit from neoadjuvant chemotherapy in resectable…”
Get full text

Gastric intramucosal pH predicts outcome after surgery for ruptured abdominal aortic aneurysm by Maynard, N.D., Taylor, P.R., Mason, R.C., Bihari, D.J.

“…The mortality associated with repair of ruptured abdominal aortic aneurysms (RAAA) remains obstinately high and many deaths result from multiple organ failure…”
Get full text